| - GRCh37:
- Chr22:21348898
- GRCh38:
- Chr22:20994609
| LZTR1 | S556N | Noonan syndrome 10, not provided | Uncertain significance (Apr 10, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:21340139-21340140
- GRCh38:
- Chr22:20985850-20985851
| LZTR1 | | Noonan syndrome 10 | Likely pathogenic (Oct 19, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr22:21342314
- GRCh38:
- Chr22:20988025
| LZTR1 | D139G | Noonan syndrome 10 | Likely pathogenic (Sep 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:21337324
- GRCh38:
- Chr22:20983035
| LZTR1 | K70M | Noonan syndrome 10 | Uncertain significance | criteria provided, single submitter |
| - GRCh37:
- Chr22:21351090
- GRCh38:
- Chr22:20996801
| LZTR1 | Q775H | Cardiovascular phenotype, Hereditary cancer-predisposing syndrome, Noonan syndrome 10
| Uncertain significance (Jul 6, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:21341842
- GRCh38:
- Chr22:20987553
| LZTR1 | V124I | Hereditary cancer-predisposing syndrome, Cardiovascular phenotype, Noonan syndrome 10, not provided | Uncertain significance (Jun 14, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:21342341
- GRCh38:
- Chr22:20988052
| LZTR1 | N148S | Noonan syndrome 10, Noonan syndrome 2, not provided
| Uncertain significance (Apr 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:21340161
- GRCh38:
- Chr22:20985872
| LZTR1 | D99Y | Noonan syndrome 10 | Uncertain significance (Oct 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:21351584
- GRCh38:
- Chr22:20997295
| LZTR1 | L824V | Noonan syndrome 10, not provided | Uncertain significance (Jun 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:21336823
- GRCh38:
- Chr22:20982534
| LZTR1 | R55W | Hereditary cancer-predisposing syndrome, Cardiovascular phenotype | Uncertain significance (Sep 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:21348906-21348907
- GRCh38:
- Chr22:20994617-20994618
| LZTR1 | | Cardiovascular phenotype, Hereditary cancer-predisposing syndrome, Noonan syndrome 10
| Uncertain significance (Jan 10, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:21346018-21346021
- GRCh38:
- Chr22:20991729-20991732
| LZTR1 | F299fs | Noonan syndrome 2, Noonan syndrome 10 | Uncertain significance (Jun 11, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:21346650
- GRCh38:
- Chr22:20992361
| LZTR1 | A381P | Noonan syndrome 10 | Uncertain significance (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:21346587
- GRCh38:
- Chr22:20992298
| LZTR1 | K360* | Schwannomatosis 2, Noonan syndrome 2, Noonan syndrome 10
| Likely pathogenic (Sep 9, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:21348920
- GRCh38:
- Chr22:20994631
| LZTR1 | | Cardiovascular phenotype, Hereditary cancer-predisposing syndrome, Noonan syndrome 10, not provided | Conflicting interpretations of pathogenicity (Jul 25, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:21347168
- GRCh38:
- Chr22:20992879
| LZTR1 | R412H | Hereditary cancer-predisposing syndrome, Cardiovascular phenotype, Schwannomatosis 2, Noonan syndrome 2, Noonan syndrome 10, not provided
| Conflicting interpretations of pathogenicity (May 21, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:21350034
- GRCh38:
- Chr22:20995745
| LZTR1 | | Hereditary cancer-predisposing syndrome, Cardiovascular phenotype, Schwannomatosis 2, Noonan syndrome 2, Noonan syndrome 10, not provided
| Likely pathogenic (Oct 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:21336682
- GRCh38:
- Chr22:20982393
| LZTR1 | G8R | Noonan syndrome 10, not provided, Hereditary cancer-predisposing syndrome, Cardiovascular phenotype | Uncertain significance (Mar 31, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:21342363
- GRCh38:
- Chr22:20988074
| LZTR1 | Y155* | not provided, Noonan syndrome 2, Noonan syndrome 10, Hereditary cancer-predisposing syndrome, Cardiovascular phenotype | Pathogenic/Likely pathogenic (Sep 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:21341845
- GRCh38:
- Chr22:20987556
| LZTR1 | V125I | Hereditary cancer-predisposing syndrome, Cardiovascular phenotype, Noonan syndrome 10, not provided | Uncertain significance (Aug 1, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:21349318
- GRCh38:
- Chr22:20995029
| LZTR1 | | Hereditary cancer-predisposing syndrome, Cardiovascular phenotype, not provided, Noonan syndrome 2, Schwannomatosis 2, Noonan syndrome 10
| Uncertain significance (Nov 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:21348208
- GRCh38:
- Chr22:20993919
| LZTR1 | | Noonan syndrome 10, not specified, Hereditary cancer-predisposing syndrome, Cardiovascular phenotype, not provided | Uncertain significance (Nov 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:21340187
- GRCh38:
- Chr22:20985898
| LZTR1 | | Hereditary cancer-predisposing syndrome, Cardiovascular phenotype, Noonan syndrome 10
| Likely pathogenic (Nov 12, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:21343095
- GRCh38:
- Chr22:20988806
| LZTR1 | S176L | Cardiovascular phenotype, Hereditary cancer-predisposing syndrome, Noonan syndrome 10
| Uncertain significance (Jul 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:21351615-21351616
- GRCh38:
- Chr22:20997326-20997327
| LZTR1 | A834fs | Noonan syndrome 10 | Pathogenic (Oct 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:21342406
- GRCh38:
- Chr22:20988117
| LZTR1 | R170W | not provided, Noonan syndrome 10, Hereditary cancer-predisposing syndrome, Cardiovascular phenotype | Uncertain significance (Oct 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:21346071
- GRCh38:
- Chr22:20991782
| LZTR1 | V316M | not provided, Cardiovascular phenotype, Hereditary cancer-predisposing syndrome, Noonan syndrome 10, not specified | Uncertain significance (Mar 2, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:21350271
- GRCh38:
- Chr22:20995982
| LZTR1 | R697W | Cardiovascular phenotype, Hereditary cancer-predisposing syndrome, Noonan syndrome 10, not provided | Uncertain significance (May 23, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:21351623
- GRCh38:
- Chr22:20997334
| LZTR1 | G837S | Noonan syndrome 10 | Uncertain significance (Mar 23, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:21350355
- GRCh38:
- Chr22:20996066
| LZTR1 | R725C | Noonan syndrome 10, Noonan syndrome and Noonan-related syndrome, Cardiovascular phenotype, Hereditary cancer-predisposing syndrome | Uncertain significance (Feb 1, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:21347187
- GRCh38:
- Chr22:20992898
| LZTR1 | R418S | Cardiovascular phenotype, Hereditary cancer-predisposing syndrome, Noonan syndrome 10, not provided | Uncertain significance (Aug 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:21336718
- GRCh38:
- Chr22:20982429
| LZTR1 | A20T | Hereditary cancer-predisposing syndrome, Cardiovascular phenotype, Noonan syndrome 10, not provided | Uncertain significance (Aug 14, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:21341794
- GRCh38:
- Chr22:20987505
| LZTR1 | A108T | Noonan syndrome 10 | Uncertain significance (Apr 3, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr22:21350240
- GRCh38:
- Chr22:20995951
| LZTR1 | | Noonan syndrome 10 | Uncertain significance (Feb 3, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr22:21346113
- GRCh38:
- Chr22:20991824
| LZTR1 | S330G | Cardiovascular phenotype, Hereditary cancer-predisposing syndrome, not provided, Noonan syndrome 10 | Uncertain significance (Aug 18, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:21350070
- GRCh38:
- Chr22:20995781
| LZTR1 | E660K | Cardiovascular phenotype, Hereditary cancer-predisposing syndrome, Noonan syndrome 10, not provided | Uncertain significance (Jan 20, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:21351025
- GRCh38:
- Chr22:20996736
| LZTR1 | N754H | Hereditary cancer-predisposing syndrome, Cardiovascular phenotype, not provided, Noonan syndrome 10 | Uncertain significance (May 31, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:21342302
- GRCh38:
- Chr22:20988013
| LZTR1 | G135V | Cardiovascular phenotype, Hereditary cancer-predisposing syndrome, Noonan syndrome 10, not provided | Uncertain significance (Apr 11, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:21351551
- GRCh38:
- Chr22:20997262
| LZTR1 | S813R | not provided, Noonan syndrome 10 | Uncertain significance (Sep 24, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:21347187
- GRCh38:
- Chr22:20992898
| LZTR1 | R418S | Noonan syndrome 10 | Uncertain significance (Jun 5, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr22:21349017
- GRCh38:
- Chr22:20994728
| LZTR1 | | Noonan syndrome 10 | Pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr22:21344745
- GRCh38:
- Chr22:20990456
| LZTR1 | F241S | Noonan syndrome 2, Noonan syndrome 10 | Likely pathogenic (Jul 7, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr22:21348931
- GRCh38:
- Chr22:20994642
| LZTR1 | R567H | Cardiovascular phenotype, Hereditary cancer-predisposing syndrome, Schwannomatosis 2, Noonan syndrome 10, not provided, not specified
| Conflicting interpretations of pathogenicity (Jan 24, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:21351028
- GRCh38:
- Chr22:20996739
| LZTR1 | R755W | Noonan syndrome 10, Hereditary cancer-predisposing syndrome, Cardiovascular phenotype, not specified, not provided | Uncertain significance (Oct 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:21348851
- GRCh38:
- Chr22:20994562
| LZTR1 | | Hereditary cancer-predisposing syndrome, Cardiovascular phenotype, not specified, Noonan syndrome 10, Noonan syndrome 2, Schwannomatosis 2, not provided | Benign/Likely benign (Oct 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:21344733
- GRCh38:
- Chr22:20990444
| LZTR1 | R237Q | Cardiovascular phenotype, Hereditary cancer-predisposing syndrome, not provided, Noonan syndrome 10 | Uncertain significance (Dec 29, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:21349285
- GRCh38:
- Chr22:20994996
| LZTR1 | R638C | Cardiovascular phenotype, Hereditary cancer-predisposing syndrome, not provided
| Uncertain significance (Aug 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:21348528
- GRCh38:
- Chr22:20994239
| LZTR1 | Y529H | Noonan syndrome 10 | Uncertain significance (Aug 25, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr22:21351010
- GRCh38:
- Chr22:20996721
| LZTR1 | Y749H | Noonan syndrome 2, Noonan syndrome 10 | Uncertain significance | no assertion criteria provided |
| - GRCh37:
- Chr22:21341832
- GRCh38:
- Chr22:20987543
| LZTR1 | H120Q | Noonan syndrome 10 | Uncertain significance | criteria provided, single submitter |
| - GRCh37:
- Chr22:21343948
- GRCh38:
- Chr22:20989659
| LZTR1 | R210* | Noonan syndrome 10, Cardiovascular phenotype, Hereditary cancer-predisposing syndrome, Schwannomatosis 2, not provided | Pathogenic (Sep 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:21347993
- GRCh38:
- Chr22:20993704
| LZTR1 | R435W | Noonan syndrome 10, not provided, Cardiovascular phenotype, Hereditary cancer-predisposing syndrome | Uncertain significance (Jun 30, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:21345973
- GRCh38:
- Chr22:20991684
| LZTR1 | R283Q | RASopathy, Noonan syndrome and Noonan-related syndrome, Noonan syndrome 10, not provided | Conflicting interpretations of pathogenicity (Feb 23, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:21345967
- GRCh38:
- Chr22:20991678
| LZTR1 | P281L | not specified, not provided, Inborn genetic diseases, Cardiovascular phenotype, Hereditary cancer-predisposing syndrome, Noonan syndrome 10
| Conflicting interpretations of pathogenicity (Aug 14, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:21348970
- GRCh38:
- Chr22:20994681
| LZTR1 | L580P | Noonan syndrome 10 | Uncertain significance | no assertion criteria provided |
| - GRCh37:
- Chr22:21336623
- GRCh38:
- Chr22:20982334
| LZTR1 | | Hereditary cancer-predisposing syndrome, Cardiovascular phenotype, Noonan syndrome 2, Schwannomatosis 2, Noonan syndrome 10, Noonan syndrome 2, not provided, Noonan syndrome 2, Noonan syndrome 10
| Conflicting interpretations of pathogenicity (Jun 18, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:21340138
- GRCh38:
- Chr22:20985849
| LZTR1 | M91T | Noonan syndrome 10, not provided | Conflicting interpretations of pathogenicity (Oct 3, 2019) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:21336686
- GRCh38:
- Chr22:20982397
| LZTR1 | G9A | Inborn genetic diseases, Noonan syndrome 10, Hereditary cancer-predisposing syndrome, Cardiovascular phenotype, not specified, not provided
| Conflicting interpretations of pathogenicity (Feb 20, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:21346527
- GRCh38:
- Chr22:20992238
| LZTR1 | R340* | not provided, Cardiovascular phenotype, Hereditary cancer-predisposing syndrome, Noonan syndrome 10, not specified, Schwannomatosis 2
| Conflicting interpretations of pathogenicity (Sep 25, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:21336719
- GRCh38:
- Chr22:20982430
| LZTR1 | A20V | Hereditary cancer-predisposing syndrome, Cardiovascular phenotype, Noonan syndrome 10, not provided | Uncertain significance (Jan 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:21350074
- GRCh38:
- Chr22:20995785
| LZTR1 | G661E | not provided, Hereditary cancer-predisposing syndrome, Cardiovascular phenotype, Noonan syndrome 10 | Uncertain significance (Oct 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:21349277
- GRCh38:
- Chr22:20994988
| LZTR1 | P635L | not provided, not specified, Hereditary cancer-predisposing syndrome, Cardiovascular phenotype | Conflicting interpretations of pathogenicity (Nov 4, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:21340137
- GRCh38:
- Chr22:20985848
| LZTR1 | M91V | not provided, Noonan syndrome 10, RASopathy
| Uncertain significance (Nov 1, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:21348981
- GRCh38:
- Chr22:20994692
| LZTR1 | E584K | Cardiovascular phenotype, Hereditary cancer-predisposing syndrome, Noonan syndrome 10, not provided, not specified | Uncertain significance (Aug 1, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:21347167
- GRCh38:
- Chr22:20992878
| LZTR1 | R412C | not specified, Non-immune hydrops fetalis, not provided, Noonan syndrome and Noonan-related syndrome, RASopathy, Schwannomatosis 2, Noonan syndrome 10 | Conflicting interpretations of pathogenicity (Jul 1, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:21346593
- GRCh38:
- Chr22:20992304
| LZTR1 | R362* | Hereditary cancer-predisposing syndrome, Cardiovascular phenotype, Noonan syndrome 2, not provided, Schwannomatosis, Schwannomatosis 2, Noonan syndrome 10, Noonan syndrome and Noonan-related syndrome, Schwannomatosis 2, See cases | Pathogenic/Likely pathogenic (Jul 7, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:21344763
- GRCh38:
- Chr22:20990474
| LZTR1 | S247N | Noonan syndrome 10 | Pathogenic (Jun 1, 2015) | no assertion criteria provided |
| - GRCh37:
- Chr22:21345975
- GRCh38:
- Chr22:20991686
| LZTR1 | R284C | Hereditary cancer-predisposing syndrome, Cardiovascular phenotype, Noonan syndrome 10, Noonan syndrome 10, Schwannomatosis 2, not provided
| Pathogenic (Jun 1, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:21344765
- GRCh38:
- Chr22:20990476
| LZTR1 | G248R | Cardiovascular phenotype, Hereditary cancer-predisposing syndrome, Inborn genetic diseases, Schwannomatosis 2, Noonan syndrome 10, Fetal cystic hygroma, Noonan syndrome 10, not provided, RASopathy
| Pathogenic/Likely pathogenic (Dec 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:21336681
- GRCh38:
- Chr22:20982392
| LZTR1 | Q10fs | Hereditary cancer-predisposing syndrome, Cardiovascular phenotype, Noonan syndrome 10, not provided | Pathogenic (Mar 2, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:21340117
- GRCh38:
- Chr22:20985828
| LZTR1 | | Hereditary cancer-predisposing syndrome, Cardiovascular phenotype, Noonan syndrome 2, Noonan syndrome 10, Schwannomatosis 2, Schwannomatosis 2, Developmental disorder, not provided, RASopathy
| Conflicting interpretations of pathogenicity (Oct 18, 2022) | criteria provided, conflicting interpretations |